Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.32 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.31 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22639374 | 0.95 | CA1 (0.34) | CA1CA2ABCG2ABCB1PIK3CD | |
| SCHEMBL20962149 | 0.94 | CA1 (0.34) | CA1CA2ABCG2PIK3CDPIK3CA | |
| SCHEMBL25263366 | 0.93 | CA1 (0.35) | CA1CA2ABCG2ABCB1PIK3CD | |
| SCHEMBL25267739 | 0.89 | CA1 (0.31) | CA1CA2 | |
| SCHEMBL20200688 | 0.87 | PIK3CD (0.36) | CA1CA2PIK3CDPIK3CAPIK3CB | |
| SCHEMBL17829446 | 0.87 | CA1 (0.35) | CA1CA2ABCG2CA12CA9 | |
| SCHEMBL22639414 | 0.86 | CA1 (0.34) | CA1CA2ABCG2ABCB1CA12 | |
| SCHEMBL23020132 | 0.83 | ADORA2A (0.36) | ABCG2 | |
| SCHEMBL21131728 | 0.83 | CA1 (0.35) | CA1CA2ABCG2ABCB1PIK3CD | |
| SCHEMBL17829448 | 0.83 | CA1 (0.35) | CA1CA2ABCG2PTPN1PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3372593-B1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEMICAL LTD (KR) | 2020-12-23 | — | — | EP | disclosed |
| US-10833278-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2020-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10833278-B2 | Compound and organic light emitting device comprising the same | CRY1, CRY2, ORC3 | CA1 3447/4885CA2 3962/4885ABCG2 1992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.